A NEW STATISTICAL PROCEDURE FOR TESTING EQUIVALENCE IN 2-GROUP COMPARATIVE BIOAVAILABILITY TRIALS

[1] A NEW PROCEDURE FOR TESTING EQUIVALENCE IN COMPARATIVE BIOAVAILABILITY AND OTHER CLINICAL-TRIALS [J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1983, 12 (23) : 2663 - 2692

[2] THE BIOAVAILABILITY OF ERYTHROMYCIN STEARATE VERSUS ENTERIC-COATED ERYTHROMYCIN BASE WHEN TAKEN IMMEDIATELY BEFORE AND AFTER FOOD [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (06) : 470 - 477

[3] SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J]. BIOMETRICS, 1977, 33 (04) : 593 - 602

[4] BIOEQUIVALENCE TESTING - A NEED TO RETHINK [J]. BIOMETRICS, 1981, 37 (03) : 589 - 591

[5] COMPARISON OF DIFFERENT METHODS FOR DECISION-MAKING IN BIOEQUIVALENCE ASSESSMENT [J]. BIOMETRICS, 1981, 37 (02) : 213 - 222

[6] METZLER C M, 1983, Clinical Research Practices and Drug Regulatory Affairs, V1, P109, DOI 10.3109/10601338309024010

[7] BIOAVAILABILITY - PROBLEM IN EQUIVALENCE [J]. BIOMETRICS, 1974, 30 (02) : 309 - 317

[8] SCHUIRMANN DJ, 1982, AUG JOINT STAT M CIN

[9] A BAYESIAN-APPROACH TO BIOEQUIVALENCE FOR THE 2X2 CHANGEOVER DESIGN [J]. BIOMETRICS, 1981, 37 (01) : 11 - 21

[10] Westlake W. J, 1979, PRINCIPLES PERSPECTI, P192

[1] A NEW PROCEDURE FOR TESTING EQUIVALENCE IN COMPARATIVE BIOAVAILABILITY AND OTHER CLINICAL-TRIALS [J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1983, 12 (23) : 2663 - 2692

[2] THE BIOAVAILABILITY OF ERYTHROMYCIN STEARATE VERSUS ENTERIC-COATED ERYTHROMYCIN BASE WHEN TAKEN IMMEDIATELY BEFORE AND AFTER FOOD [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (06) : 470 - 477

[3] SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J]. BIOMETRICS, 1977, 33 (04) : 593 - 602

[4] BIOEQUIVALENCE TESTING - A NEED TO RETHINK [J]. BIOMETRICS, 1981, 37 (03) : 589 - 591

[5] COMPARISON OF DIFFERENT METHODS FOR DECISION-MAKING IN BIOEQUIVALENCE ASSESSMENT [J]. BIOMETRICS, 1981, 37 (02) : 213 - 222

[6] METZLER C M, 1983, Clinical Research Practices and Drug Regulatory Affairs, V1, P109, DOI 10.3109/10601338309024010

[7] BIOAVAILABILITY - PROBLEM IN EQUIVALENCE [J]. BIOMETRICS, 1974, 30 (02) : 309 - 317

[8] SCHUIRMANN DJ, 1982, AUG JOINT STAT M CIN

[9] A BAYESIAN-APPROACH TO BIOEQUIVALENCE FOR THE 2X2 CHANGEOVER DESIGN [J]. BIOMETRICS, 1981, 37 (01) : 11 - 21

[10] Westlake W. J, 1979, PRINCIPLES PERSPECTI, P192